Medical Devices
-
Baxter hires CFO from Smith & Nephew
John Rogers, who has experience leading change at companies, is expected to help Baxter’s turnaround gain traction. He joins Baxter after the company sold two business units.
By Susan Kelly • Aug. 20, 2026 -
Vitestro secures FDA nod for robotic blood draw device
The Food and Drug Administration hailed the potential of the first-of-its-kind device to counter the U.S. phlebotomist shortage.
By Nick Paul Taylor • Aug. 20, 2026 -
Explore the Trendline➔
Sarah Silbiger via Getty Images
TrendlineTop 5 stories from MedTech Dive
From the effects of layoffs at the Food and Drug Administration and President Donald Trump’s tariff policies to the top medtech trends of 2026, here is a collection of top stories from MedTech Dive.
By MedTech Dive staff -
GE HealthCare names new CFO
William Grogan will take over the chief finance job vacated by Jay Saccaro. Stifel analysts called Grogan’s “no-nonsense” mindset on setting expectations a strength.
By Nick Paul Taylor • Aug. 19, 2026 -
Deep Dive
5 questions on Abbott’s glucose-ketone sensors
As Abbott prepares to launch its first dual-analyte sensor, endocrinologists talked to MedTech Dive about considerations for continuous ketone monitoring.
By Elise Reuter • Aug. 19, 2026 -
Baxter’s interim CFO leaves for Cardinal Health
Anita Zielinski will join Cardinal Health in November as its new chief accounting officer.
By Elise Reuter • Aug. 18, 2026 -
J&J’s Monarch robot wins FDA nod for AI features
The lung bronchoscopy robot adds improvements that include new tools for pre-procedure planning and updated navigation and visual guidance during the procedure.
By Susan Kelly • Aug. 17, 2026 -
AMS secures shareholder support for planned sale to H.B. Fuller
Buying tissue-healing company AMS will bring H.B. Fuller into the markets for formulated biosurgicals and mechanical closures.
By Nick Paul Taylor • Updated Aug. 14, 2026 -
Cook Medical discloses cyber incident stemming from a scam
An outside party gained access to some company systems, but the medical device maker found no evidence that sensitive or protected data was obtained and said its operations are running normally.
By Susan Kelly • Aug. 13, 2026 -
BD fully enrolls trial of resorbable mesh for hernia prevention
BD called completing enrollment in the study “a significant milestone in its advanced tissue regeneration strategy and expansion efforts.”
By Nick Paul Taylor • Aug. 13, 2026 -
Q&A
Inside Senseonics’ commercial overhaul and what’s next
The diabetes tech firm recently brought its sales and marketing teams in-house after taking over commercialization of its device from Ascensia Diabetes Care.
By Elise Reuter • Aug. 13, 2026 -
Medtronic veteran departs for CEO role at heart valve startup
Bill Shields, who led transcatheter mitral and tricuspid therapies at Medtronic, has joined Versa Vascular, developer of a valve repair treatment.
By Susan Kelly • Aug. 12, 2026 -
Abbott, Google to combine glucose data with AI coaching
The multiyear partnership will connect Abbott’s over-the-counter Lingo sensor and the Google Health app.
By Elise Reuter • Aug. 12, 2026 -
Philips authorizes largest shareholder to increase stake to 22%
Philips framed the revised agreement with Exor, the holding company of Italy’s billionaire Agnelli family, as evidence of confidence in its strategy.
By Nick Paul Taylor • Aug. 12, 2026 -
Ortho firms unfazed by Medicare joint replacement changes
Shifting more responsibility for procedure costs to hospitals is unlikely to pressure prices for orthopedic implants, CEOs said.
By Elise Reuter • Aug. 11, 2026 -
CMS seeks feedback on faster coverage for breakthrough devices
The proposed “RAPID” pathway could help some new medical devices get national Medicare coverage within months of FDA authorization.
By Susan Kelly • Aug. 11, 2026 -
Teledyne inks $1.1B takeover of Varex Imaging
Buying Varex will increase Teledyne’s exposure to the healthcare market. Teledyne said the companies’ imaging technologies complement each other with minimal overlap.
By Nick Paul Taylor • Aug. 11, 2026 -
Device firms back latest MDUFA deal, while patients want more postmarket safety
The latest agreement includes higher fees for overseas firms, hiring transparency requirements and greater use of real-world evidence.
By Elise Reuter • Aug. 10, 2026 -
IRhythm grows heart monitoring leadership with $288M VitalConnect buy
Acquiring VitalConnect could unlock a $1 billion cardiac monitoring market that is only partly served by iRhythm’s existing devices.
By Nick Paul Taylor • Aug. 10, 2026 -
Philips forms 6 patient monitoring partnerships
By employing wearable devices to support patient monitoring between the hospital and home, Philips hopes to improve care continuity.
By Nick Paul Taylor • Aug. 7, 2026 -
Medtronic gets CE mark for ablation to treat ventricular tachycardia
Older ablation approaches for ventricular tachycardia have been suboptimal, Medtronic said. The company plans to bring a more effective treatment for the life-threatening heart condition.
By Susan Kelly • Aug. 7, 2026 -
Zimmer Biomet sales force revamp going better than expected, CEO says
The restructuring, intended to give Zimmer Biomet a fully dedicated sales force, is expected to be complete by the end of 2027.
By Elise Reuter • Aug. 6, 2026 -
Solventum plans software separation to become ‘true medtech company’
The software business needs “a different investment level” to quickly realize its potential, Solventum’s CEO said.
By Nick Paul Taylor • Aug. 6, 2026 -
Q&A
Medtronic on the future of AI-assisted surgery
Medtronic’s George Murgatroyd says an advanced computing platform that works with the company’s Hugo robot will power AI algorithms that can assist surgeons as they operate.
By Susan Kelly • Aug. 5, 2026 -
BD recalls intraosseous needle sets associated with 4 deaths
Some needles were manufactured with incorrect dimensions, making it difficult to remove the stylet after placement.
By Elise Reuter • Aug. 5, 2026 -
STAAR Surgical appoints Warren Foust as permanent CEO
The implantable eye lens company began searching for a new CEO shortly after its sale to Alcon collapsed in January.
By Nick Paul Taylor • Aug. 5, 2026